Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)

被引:27
|
作者
Talaei, Mohammad [1 ]
Faustini, Sian [2 ]
Holt, Hayley [1 ,3 ,4 ]
Jolliffe, David A. [1 ,3 ]
Vivaldi, Giulia [1 ,3 ]
Greenig, Matthew [1 ]
Perdek, Natalia [1 ]
Maltby, Sheena [1 ]
Bigogno, Carola M. [1 ]
Symons, Jane [5 ]
Davies, Gwyneth A. [6 ]
Lyons, Ronan A. [6 ]
Griffiths, Christopher J. [1 ,4 ]
Kee, Frank [7 ]
Sheikh, Aziz [8 ]
Richter, Alex G. [2 ]
Shaheen, Seif O. [1 ]
Martineau, Adrian R. [1 ,3 ,4 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Populat Hlth, London, England
[2] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Queen Mary Univ London, Asthma UK Ctr Appl Res, London, England
[5] Jane Symons Media, London, England
[6] Swansea Univ, Med Sch, Populat Data Sci, Singleton Pk, Swansea, W Glam, Wales
[7] Queens Univ Belfast, Ctr Publ Hlth Res NI, Belfast, Antrim, North Ireland
[8] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland
基金
英国科研创新办公室;
关键词
SARS-CoV-2; Serology; Ethnicity; Diet; Micronutrients; Lifestyle; Exercise; Obesity; Alcohol; Occupation; INFECTION;
D O I
10.1186/s12916-022-02286-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prospective population-based studies investigating multiple determinants of pre-vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective population-based study in SARS-CoV-2 vaccine-naive UK adults recruited between May 1 and November 2, 2020, without a positive swab test result for SARS-CoV-2 prior to enrolment. Information on 88 potential sociodemographic, behavioural, nutritional, clinical and pharmacological risk factors was obtained through online questionnaires, and combined IgG/IgA/IgM responses to SARS-CoV-2 spike glycoprotein were determined in dried blood spots obtained between November 6, 2020, and April 18, 2021. We used logistic and linear regression to estimate adjusted odds ratios (aORs) and adjusted geometric mean ratios (aGMRs) for potential determinants of SARS-CoV-2 seropositivity (all participants) and antibody titres (seropositive participants only), respectively. Results Of 11,130 participants, 1696 (15.2%) were seropositive. Factors independently associated with higher risk of SARS-CoV-2 seropositivity included frontline health/care occupation (aOR 1.86, 95% CI 1.48-2.33), international travel (1.20, 1.07-1.35), number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.29, 1.06-1.57, P-trend = 0.01), body mass index (BMI) >= 25 vs. < 25 kg/m(2) (1.24, 1.11-1.39), South Asian vs. White ethnicity (1.65, 1.10-2.49) and alcohol consumption >= 15 vs. 0 units/week (1.23, 1.04-1.46). Light physical exercise associated with lower risk (0.80, 0.70-0.93, for >= 10 vs. 0-4 h/week). Among seropositive participants, higher titres of anti-Spike antibodies associated with factors including BMI >= 30 vs. < 25 kg/m(2) (aGMR 1.10, 1.02-1.19), South Asian vs. White ethnicity (1.22, 1.04-1.44), frontline health/care occupation (1.24, 95% CI 1.11-1.39), international travel (1.11, 1.05-1.16) and number of visits to shops and other indoor public places (>= 5 vs. 0/week: 1.12, 1.02-1.23, P-trend = 0.01); these associations were not substantially attenuated by adjustment for COVID-19 disease severity. Conclusions Higher alcohol consumption and lower light physical exercise represent new modifiable risk factors for SARS-CoV-2 infection. Recognised associations between South Asian ethnic origin and obesity and higher risk of SARS-CoV-2 seropositivity were independent of other sociodemographic, behavioural, nutritional, clinical, and pharmacological factors investigated. Among seropositive participants, higher titres of anti-Spike antibodies in people of South Asian ancestry and in obese people were not explained by greater COVID-19 disease severity in these groups.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)
    Holt, Hayley
    Talaei, Mohammad
    Greenig, Matthew
    Zenner, Dominik
    Symons, Jane
    Relton, Clare
    Young, Katherine S.
    Davies, Molly R.
    Thompson, Katherine N.
    Ashman, Jed
    Rajpoot, Sultan Saeed
    Kayyale, Ahmed Ali
    El Rifai, Sarah
    Lloyd, Philippa J.
    Jolliffe, David
    Timmis, Olivia
    Finer, Sarah
    Iliodromiti, Stamatina
    Miners, Alec
    Hopkinson, Nicholas S.
    Alam, Bodrul
    Lloyd-Jones, Graham
    Dietrich, Thomas
    Chapple, Iain
    Pfeffer, Paul E.
    McCoy, David
    Davies, Gwyneth
    Lyons, Ronan A.
    Griffiths, Christopher
    Kee, Frank
    Sheikh, Aziz
    Breen, Gerome
    Shaheen, Seif O.
    Martineau, Adrian R.
    THORAX, 2022, 77 (09) : 900 - 912
  • [32] Seroprevalence of SARS-CoV-2 Antibodies Among Blood Donors in Malaysia During the Pre-Vaccination Period
    Shukri, A. M. A.
    Adnan, A.
    Mui, W. Seok
    Mohamad, M.
    Kamal, F.
    Khalid, Z.
    Nawi, S. F. A. Mohd
    Abu Amin, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S33 - S34
  • [33] Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases
    Bakasis, Athanasios-Dimitrios
    Bitzogli, Kleopatra
    Mouziouras, Dimitrios
    Pouliakis, Abraham
    Roumpoutsou, Maria
    Goules, Andreas V.
    Androutsakos, Theodoros
    VIRUSES-BASEL, 2022, 14 (02):
  • [34] SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
    Bartsch, Yannic C.
    St Denis, Kerri J.
    Kaplonek, Paulina
    Kang, Jaewon
    Lam, Evan C.
    Burns, Madeleine D.
    Farkas, Eva J.
    Davis, Jameson P.
    Boribong, Brittany P.
    Edlow, Andrea G.
    Fasano, Alessio
    Shreffler, Wayne G.
    Zavadska, Dace
    Johnson, Marina
    Goldblatt, David
    Balazs, Alejandro B.
    Yonker, Lael M.
    Alter, Galit
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (672)
  • [35] Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
    Bhavsar, Disha
    Singh, Gagandeep
    Sano, Kaori
    Gleason, Charles
    Srivastava, Komal
    Carreno, Juan Manuel
    Simon, Viviana
    Krammer, Florian
    MBIO, 2023, 14 (06):
  • [36] Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques
    Willcox, Alexandra C.
    Sung, Kevin
    Garrett, Meghan E.
    Galloway, Jared G.
    Erasmus, Jesse H.
    Logue, Jennifer K.
    Hawman, David W.
    Chu, Helen Y.
    Hasenkrug, Kim J.
    Fuller, Deborah H.
    Matsen, Frederick A.
    Overbaugh, Julie
    PLOS PATHOGENS, 2022, 18 (04)
  • [37] A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
    Alfego, David
    Sullivan, Adam
    Poirier, Brian
    Williams, Jonathan
    Adcock, Dorothy
    Letovsky, Stanley
    ECLINICALMEDICINE, 2021, 36
  • [38] Social determinants of ethnic disparities in SARS-CoV-2 infection: UK Biobank SARS-CoV-2 Serology Study
    Omiyale, Wemimo
    Holliday, Jo
    Doherty, Nicola
    Callen, Howard
    Wood, Natasha
    Horn, Edward
    Burnett, Frances
    Young, Allen
    Lewington, Sarah
    Fry, Dan
    Besevic, Jelena
    Conroy, Megan
    Sheard, Simon
    Feng, Qi
    Welsh, Samantha
    Effingham, Mark
    Young, Alan
    Collins, Rory
    Lacey, Ben
    Allen, Naomi
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2024, 78 (01) : 3 - 10
  • [39] Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
    Naveed, Zaeema
    Li, Julia
    Spencer, Michelle
    Wilton, James
    Naus, Monika
    Garcia, Hector Alexander Velasquez
    Otterstatter, Michael
    Janjua, Naveed Zafar
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (45) : E1529 - E1536
  • [40] A Longitudinal Analysis of SARS-CoV-2 Antibody Responses Among People With HIV
    Alcaide, Maria L.
    Nogueira, Nicholas F.
    Salazar, Ana S.
    Montgomerie, Emily K.
    Rodriguez, Violeta J.
    Raccamarich, Patricia D.
    Barreto, Irma T.
    McGaugh, Angela
    Sharkey, Mark E.
    Mantero, Alejandro M.
    Rodriguez, Allan E.
    Beauchamps, Laura
    Jones, Deborah L.
    FRONTIERS IN MEDICINE, 2022, 9